We also identified the downstream targets of Rock2, such as Add1, that promote synaptic disorders, and disruption of the phosphorylation of Add1 by a specific peptide also rescued dendritic abnormalities and learning memory deficits in AD. Here, ROCK2 is linked to Alzheimer disease.